Jean George Insider Trading $XLRN ACCELERON PHARMA INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jean George.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jean George. Jean George is Director in CORNERSTONE THERAPEUTICS INC ($CRTX) and Director in ACCELERON PHARMA INC ($XLRN) and Director in Zeltiq Aesthetics Inc ($ZLTQ) and Director in CATABASIS PHARMACEUTICALS INC ($CATB) and Director in Calithera Biosciences, Inc. ($CALA).
Jean George in ACCELERON PHARMA INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Jean George: Director
Holdings: 5,127 shares
Current Value: $121,715
Latest Transaction: Jan 24 2020
$XLRN Market Capitalization: $879.48M
$XLRN Previous Close: $23.74
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Jean George in ACCELERON PHARMA INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, XLRN, CALA, CATB, CRTX, ZLTQ
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 24 2020 | XLRN | ACCELERON PHARMA I ... | George Jean | Director | Option Exercise | A | 52.99 | 8,185 | 433,723 | 8,185 | |
| Jan 24 2020 | XLRN | ACCELERON PHARMA I ... | George Jean | Director | Grant | A | 0.00 | 1,377 | 0 | 5,127 | 3.8 K to 5.1 K (+36.72 %) |
| Jun 28 2019 | XLRN | ACCELERON PHARMA I ... | George Jean | Director | Option Exercise | M | 30.17 | 7,500 | 226,275 | 0 | |
| Jun 28 2019 | XLRN | ACCELERON PHARMA I ... | George Jean | Director | Option Exercise | M | 27.97 | 10,000 | 279,700 | 0 | |
| Jun 28 2019 | XLRN | ACCELERON PHARMA I ... | George Jean | Director | Option Exercise | M | 24.11 | 20,000 | 482,200 | 0 | |
| Jun 28 2019 | XLRN | ACCELERON PHARMA I ... | George Jean | Director | Sell | S | 41.17 | 11,812 | 486,300 | 0 | 11.8 K to 0 (-100.00 %) |
| Jun 28 2019 | XLRN | ACCELERON PHARMA I ... | George Jean | Director | Buy | J | 0.00 | 11,812 | 0 | 11,812 | 0 to 11.8 K |
| Jun 28 2019 | XLRN | ACCELERON PHARMA I ... | George Jean | Director | Sell | J | 0.00 | 11,812 | 0 | 3,750 | 15.6 K to 3.8 K (-75.90 %) |
| Jun 28 2019 | XLRN | ACCELERON PHARMA I ... | George Jean | Director | Sell | S | 39.16 | 25,688 | 1,005,942 | 15,562 | 41.3 K to 15.6 K (-62.27 %) |
| Jun 28 2019 | XLRN | ACCELERON PHARMA I ... | George Jean | Director | Buy | M | 30.17 | 7,500 | 226,275 | 41,250 | 33.8 K to 41.3 K (+22.22 %) |
| Jun 28 2019 | XLRN | ACCELERON PHARMA I ... | George Jean | Director | Buy | M | 27.97 | 10,000 | 279,700 | 33,750 | 23.8 K to 33.8 K (+42.11 %) |
| Jun 28 2019 | XLRN | ACCELERON PHARMA I ... | George Jean | Director | Buy | M | 24.11 | 20,000 | 482,200 | 23,750 | 3.8 K to 23.8 K (+533.33 %) |
| Jan 29 2019 | XLRN | ACCELERON PHARMA I ... | George Jean | Director | Option Exercise | A | 41.64 | 7,500 | 312,300 | 7,500 | |
| Jan 29 2019 | XLRN | ACCELERON PHARMA I ... | George Jean | Director | Grant | A | 0.00 | 1,250 | 0 | 3,750 | 2.5 K to 3.8 K (+50.00 %) |
| Mar 05 2018 | XLRN | ACCELERON PHARMA I ... | George Jean | Director | Option Exercise | A | 40.61 | 7,500 | 304,575 | 7,500 | |
| Mar 05 2018 | XLRN | ACCELERON PHARMA I ... | George Jean | Director | Grant | A | 0.00 | 1,250 | 0 | 2,500 | 1.3 K to 2.5 K (+100.00 %) |
| Dec 18 2017 | XLRN | ACCELERON PHARMA I ... | George Jean | Director | Sell | S | 35.73 | 105,122 | 3,756,009 | 0 | 105.1 K to 0 (-100.00 %) |
| Mar 14 2017 | XLRN | ACCELERON PHARMA I ... | George Jean | Director | Option Exercise | A | 30.17 | 7,500 | 226,275 | 7,500 | |
| Mar 14 2017 | XLRN | ACCELERON PHARMA I ... | George Jean | Director | Grant | A | 0.00 | 1,250 | 0 | 1,250 | 0 to 1.3 K |
| Dec 19 2016 | XLRN | ACCELERON PHARMA I ... | George Jean | Director | Option Exercise | M | 5.88 | 127,122 | 747,477 | 0 | |
| Dec 19 2016 | XLRN | ACCELERON PHARMA I ... | George Jean | Director | Payment of Exercise | F | 33.98 | 22,000 | 747,560 | 105,122 | 127.1 K to 105.1 K (-17.31 %) |
| Dec 19 2016 | XLRN | ACCELERON PHARMA I ... | George Jean | Director | Buy | M | 5.88 | 127,122 | 747,477 | 127,122 | 0 to 127.1 K |
| Nov 18 2016 | XLRN | ACCELERON PHARMA I ... | George Jean | Director | Sell | S | 38.05 | 379,464 | 14,438,605 | 0 | 379.5 K to 0 (-100.00 %) |
| Nov 18 2016 | XLRN | ACCELERON PHARMA I ... | George Jean | Director | Sell | S | 39.13 | 41,112 | 1,608,713 | 379,464 | 420.6 K to 379.5 K (-9.78 %) |
| Nov 18 2016 | XLRN | ACCELERON PHARMA I ... | George Jean | Director | Sell | S | 41.39 | 32,929 | 1,362,931 | 420,576 | 453.5 K to 420.6 K (-7.26 %) |
| Oct 04 2016 | XLRN | ACCELERON PHARMA I ... | George Jean | Director | Sell | S | 35.50 | 857,145 | 30,428,648 | 453,505 | 1.3 M to 453.5 K (-65.40 %) |
| Mar 07 2016 | XLRN | ACCELERON PHARMA I ... | George Jean | Director | Option Exercise | A | 27.97 | 10,000 | 279,700 | 10,000 |
Page: 1